• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Panbela Therapeutics Inc (OP: PBLA )

    0.4003 +0.0503 (+14.37%)
    Streaming Delayed Price Updated: 3:48 PM EDT, Oct 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 55,726
    Open 0.3500
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 0.3500
    Today's Range 0.3500 - 0.4392
    52wk Range 0.3000 - 0.9500
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024
    PBLA stock results show that Panbela Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -41.98%
    -41.98%
    1 Month
    +21.30%
    +21.30%
    3 Month
    +8.93%
    +8.93%
    6 Month
    -25.82%
    -25.82%
    1 Year
    -41.98%
    -41.98%

    More News

    Read More
    Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Panbela Announces Oral Presentation at Digestive Disease Week (DDW):
    From Panbela Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.